Albert A. Holman, III
Board Member
BridgeBio Oncology Therapeutics, Inc. (BBOT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Albert A. Holman, III
Albert A. Holman, III is recorded as Board Member at BridgeBio Oncology Therapeutics, Inc. (BBOT). BridgeBio Oncology Therapeutics, Inc. reported in an 8-K filed February 10, 2025 that Albert A. Holman, III was appointed Class III director, effective February 8, 2025.
“On February 8, 2025, the board of directors (the "Board") of Helix Acquisition Corp. II (the "Company"), , appointed Mr. Albert A. Holman, III to the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-02-08–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at BridgeBio Oncology Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Eli Wallace CEO, Board Member
- Pedro Beltran, Ph.D. CEO, Board Member
- Pedro J. Beltran, Ph.D. CEO, Board Member
- Neil Kumar, Ph.D. Chairman
- Idan Elmelech CFO, COO
- Uneek Mehra CFO
- Marc Cobo Chief Accounting Officer
- Bihua Chen Board Member
- Frank McCormick Board Member
- Frank P. McCormick Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.